European innovation reaches EU population: MIG Fonds` portfolio company BioNTech achieves positive CHMP opinion for the first COVID-19 and mRNA vaccine
“Venture Capital Journal” presents, in an in-depth feature, the opportunities in the animal health market for VC investors, including quotes from Andreas Kastenbauer, Partner at MIG Capital.